Various substrates of PTPN2 play important roles in the genesis and progression of breast cancer amongst others the epidermal growth factor receptor (EGFR), STAT3, and proposedly the Met receptor (Sangwan et al. 2008; Tiganis et al. 1998, 1999; Yamamoto et al. 2002). This evidence concerns the gene EGFR and breast carcinoma.